Clinical Guides
Heart Failure
A clinically focused adult guide to recognising heart failure as a clinical syndrome, confirming its phenotype and cause, treating congestion and disease-modifying indications safely, and escalating acute deterioration in Indian practice.
MedNext Academy | 13 min read
Heart Failure
A clinically focused adult guide to recognising heart failure as a clinical syndrome, confirming its phenotype and cause, treating congestion and disease-modifying indications safely, and escalating acute deterioration in Indian practice.
Summary
Heart failure (HF) is a clinical syndrome of symptoms and signs caused by a structural or functional cardiac abnormality and supported by raised natriuretic peptides or objective evidence of pulmonary or systemic congestion. It is not synonymous with a low ejection fraction, oedema, breathlessness or a chest radiograph finding. Left-ventricular ejection fraction (LVEF) helps phenotype the syndrome: the 2022 AHA/ACC/HFSA guideline defines HFrEF as LVEF 40% or less, HF with mildly reduced EF as 41–49%, and HF with preserved EF as 50% or more when there is evidence of increased filling pressures.
The first clinical distinction is acute instability versus stable chronic disease. Pulmonary oedema, hypoxaemia, shock, altered consciousness, acute coronary syndrome, serious arrhythmia, severe hypertension or infection can make HF a time-critical emergency. Simultaneously identify precipitating factors such as ischaemia, arrhythmia, uncontrolled blood pressure, infection, anaemia, renal deterioration, thyroid disease, non-adherence, harmful medicines or valve disease. Diuretic response does not establish the diagnosis and a normal peripheral oedema examination does not exclude congestion.
Long-term care combines cause-directed treatment, congestion control, disease-modifying therapy where indicated, education, rehabilitation and follow-up. This is an educational review candidate, not a personal treatment plan. It does not replace an Indian hospital emergency pathway, echocardiography report, prescribing supervision, pregnancy or renal assessment, or shared decisions about affordability and goals of care.
How Common Is It?
HF is common globally, but its prevalence is not a single transferable percentage. Case definitions differ: some studies count diagnosed HF, some require reduced EF, some include preserved EF, and some use administrative data. WHO identifies cardiovascular disease as the leading cause of death globally, but that fact should not be converted into an Indian HF prevalence, admission rate or mortality figure. India has heterogeneous population age structures, rheumatic and ischaemic disease patterns, hypertension, diabetes, air pollution, access to echocardiography and referral pathways, so local registries are needed for local estimates.
The syndrome becomes more frequent with ageing and multimorbidity, but younger adults can present with cardiomyopathy, valvular disease, congenital disease, myocarditis, peripartum disease or severe hypertension. Survival and admission burden depend on phenotype, renal function, blood pressure, frailty, access to disease-modifying treatment, device and valve services, and the precipitant. A person with preserved EF may have substantial exercise limitation and repeated congestion despite not meeting an HFrEF definition.
For clinical practice, functional trajectory is as important as population frequency: new orthopnoea, reduced walking distance, recurrent emergency visits, weight change, oedema or escalating diuretic use merit review. International guideline trials and WHO data provide context, but Indian community burden and access estimates remain uncertain in this source set. A service should audit its own diagnostic completion, admissions, readmissions, mortality and medicine continuity rather than borrow a headline number.
Risk Factors
Common antecedents include coronary artery disease or previous myocardial infarction, hypertension, diabetes, valvular heart disease, atrial fibrillation, cardiomyopathy, congenital heart disease, chronic kidney disease, obesity, alcohol or cardiotoxic drug exposure and infiltrative or inflammatory disease. Risk factors identify people who need cardiovascular prevention and earlier evaluation of symptoms; they do not confirm HF. A careful history asks about exertional breathlessness, fatigue, orthopnoea, paroxysmal nocturnal dyspnoea, ankle swelling, palpitations, chest pain, syncope, fever, pregnancy timing, family cardiomyopathy and every medicine.
Decompensation often follows a trigger rather than spontaneous ‘fluid overload’. Look for acute coronary syndrome, rapid atrial fibrillation or other arrhythmia, uncontrolled hypertension, infection, pulmonary embolism, anaemia, thyroid dysfunction, renal decline, high salt intake, missed diuretics, over-the-counter NSAIDs, corticosteroids, negative inotropes where unsuitable, alcohol or illicit drugs. Verify rather than assume non-adherence; cost, stock-out, adverse effects, misunderstanding, depression and transport can interrupt treatment.
In India, rheumatic valvular disease, untreated hypertension, delayed ischaemic presentation, tuberculosis or other infection when clinically plausible, anaemia, pregnancy-related cardiac disease and limited follow-up may shape individual risk. These are differential considerations, not a basis to stereotype a patient or order indiscriminate testing. The guide does not provide an Indian risk calculator. Prevention requires blood-pressure and diabetes care, tobacco cessation, appropriate physical activity, vaccination and cause-specific treatment through the local health system.
Diagnosis
History
Establish time course, baseline function, exercise tolerance, orthopnoea, nocturnal symptoms, oedema, abdominal distension, reduced appetite, cough, wheeze, chest pain, palpitations, syncope, fever, urinary output, weight change and medication exposure. Clarify previous echocardiograms, myocardial infarction, hypertension, valve disease, atrial fibrillation, cardiotoxic therapy, alcohol or stimulant exposure, family cardiomyopathy and pregnancy/postpartum timing. Acute onset with chest pain, severe breathlessness, syncope or confusion requires emergency assessment rather than an outpatient diagnostic sequence.
Examination
Record respiratory rate, oxygen saturation, pulse and rhythm, blood pressure, temperature, mental state, perfusion and weight when feasible. Look for raised jugular venous pressure, crackles, pleural effusion signs, displaced apex, S3, murmurs, hepatomegaly, ascites and peripheral oedema, while recognising that any single sign lacks sensitivity. Cold extremities, hypotension, oliguria, cyanosis, altered consciousness or severe respiratory distress suggests hypoperfusion or respiratory failure. Examine for anaemia, thyroid disease, infection, venous thrombosis and the precipitating cause.
Investigations
ECG, chest radiography, natriuretic peptides, renal function, electrolytes, glucose, blood count, liver tests, thyroid testing and iron studies are selected to confirm syndrome, assess severity, establish cause or enable safe treatment. Echocardiography evaluates ventricular function, valves, wall motion and structural disease; LVEF alone is insufficient, especially for preserved EF. The AHA/ACC/HFSA guideline recommends assessment of possible cause and routine laboratory evaluation including blood count, urinalysis, electrolytes, urea nitrogen, creatinine, glucose, lipids, liver and thyroid tests and iron studies. Troponin, cultures, D-dimer, coronary evaluation, cardiac MRI or invasive testing depend on the clinical question. Interpret natriuretic peptides in the context of atrial fibrillation, age, obesity, kidney disease and acute illness.
Differential Diagnosis
Breathlessness and oedema are syndromes, not proof of HF. COPD or asthma, pneumonia, tuberculosis when clinically supported, pulmonary embolism, pleural disease, anaemia, obesity, deconditioning, renal disease, cirrhosis, nephrotic syndrome, venous insufficiency, hypothyroidism and medication-related oedema can mimic or coexist with HF. Wheeze may occur in pulmonary oedema; crackles may be absent in chronic congestion. A normal oxygen saturation at rest does not explain exertional limitation.
Acute dyspnoea requires parallel consideration of acute coronary syndrome, serious arrhythmia, hypertensive emergency, sepsis, pulmonary embolism and pneumothorax. Chest pain, diaphoresis, hypotension, new ECG changes or rising troponin needs an acute coronary syndrome pathway even when congestion is present. A rapid irregular pulse may be a precipitant, consequence or independent cause of symptoms. Pregnancy or postpartum breathlessness needs cardio-obstetric and thromboembolic considerations rather than automatic attribution to normal physiology.
The phenotype can also be mistaken. Preserved EF does not rule out HF if symptoms, signs and objective evidence of raised filling pressures are present. Conversely, a reduced EF on an older report does not prove that current breathlessness is due to congestion. Valvular, pericardial, restrictive, infiltrative and high-output states need expert interpretation. Reassess after each result: a raised peptide supports but does not identify cause; a response to diuretic may occur in renal or hepatic fluid retention and does not replace structural assessment.
Management
Treat instability first. Sit an acutely breathless patient upright if tolerated, assess airway, breathing, circulation and perfusion, monitor continuously when indicated, obtain ECG and targeted tests, and call senior or emergency support. Oxygen is for hypoxaemia, not routine relief of dyspnoea; ventilatory support, intravenous loop diuretic, vasodilator or inotrope decisions require haemodynamic assessment and a current emergency protocol. Search and treat a precipitant at the same time. Cardiogenic shock, acute coronary syndrome, dangerous arrhythmia, severe valvular disease or refractory pulmonary oedema needs urgent higher-level care.
For chronic symptomatic fluid retention, diuretics relieve congestion and improve symptoms; dose and route are individualised to volume status, renal function, electrolytes, blood pressure, prior response and monitoring capacity. In HFrEF, the 2022 AHA/ACC/HFSA guideline identifies four foundational medication classes: an angiotensin receptor-neprilysin inhibitor, ACE inhibitor or ARB when appropriate; an evidence-based beta blocker; a mineralocorticoid receptor antagonist; and an SGLT2 inhibitor. Start and titrate one safely rather than reflexively adding every class without checking blood pressure, creatinine, potassium, diabetes treatment, contraindications and affordability.
Lifestyle advice includes sodium and fluid advice tailored to congestion and local protocol, daily symptom or weight awareness where feasible, physical activity or rehabilitation when stable, vaccination, tobacco and alcohol counselling, and written action plans. Treat ischaemia, valve disease, atrial fibrillation, hypertension, diabetes, iron deficiency and sleep-disordered breathing when present. Device, revascularisation, valve or advanced-HF decisions require phenotype, prognosis, anatomy, patient preference and specialist assessment; they are not determined by one EF threshold.
Prescribing Information
Prescribing in HF is high-risk because benefit and harm depend on phenotype, volume status, blood pressure, renal function, potassium, rhythm, pregnancy possibility and concurrent medicines. Reconcile every drug, including over-the-counter NSAIDs, herbal products, steroids, decongestants and diabetes medicines. Before initiating or increasing a renin-angiotensin system agent, mineralocorticoid receptor antagonist, SGLT2 inhibitor or diuretic, obtain a recent clinical assessment and a laboratory plan. Repeat renal function and electrolytes after relevant changes according to the local protocol and act on symptomatic hypotension, rising creatinine, hyperkalaemia, hypokalaemia or dehydration rather than treating a laboratory value in isolation.
For HFrEF, guideline-directed classes should be considered with their indicated eligibility and contraindications; exact starting doses and titration schedules must come from the current Indian product label, institutional protocol and specialist or prescriber review. Do not combine an ACE inhibitor with an angiotensin receptor-neprilysin inhibitor; an appropriate washout is required when changing. Mineralocorticoid receptor antagonists require potassium and renal surveillance. SGLT2 inhibitors require sick-day, genital infection and ketoacidosis counselling, particularly in people using insulin or with low intake.
Loop diuretics relieve congestion but do not replace disease-modifying treatment in eligible HFrEF. Under-diuresis risks ongoing congestion; over-diuresis can cause hypotension, kidney injury and electrolyte disturbance. NSAIDs can worsen fluid retention and renal function. Avoid casual advice to stop all HF medicines during an intercurrent illness: seek prescriber guidance based on volume, blood pressure, renal function and the drug. Pregnancy, breastfeeding, severe renal dysfunction, hepatic disease, frailty and polypharmacy require individual specialist or pharmacist input.
When to Refer
Emergency transfer is needed for severe resting breathlessness, hypoxaemia, pulmonary oedema, shock or hypoperfusion, syncope with instability, new confusion, severe chest pain, sustained ventricular arrhythmia, rapid unstable atrial fibrillation, suspected acute valve failure, or failure to respond to initial monitored treatment. Transfer should not wait for every outpatient test. Give a structured handover with onset, baseline function, observations and perfusion, ECG, treatments and times, oxygen or ventilation needs, urine output, key laboratory results, pregnancy status and the suspected precipitant.
Cardiology referral is appropriate for a new suspected HF diagnosis, reduced or unexplained EF, significant valve disease, recurrent admission, persistent symptoms despite an initial plan, intolerance of guideline-directed medicines, unexplained syncope, inherited cardiomyopathy concern, advanced device or revascularisation question, pulmonary hypertension or diagnostic uncertainty. Specialist review is also valuable in preserved EF because diagnosis requires evidence of raised filling pressures and management depends on comorbidity and cause. Cardio-obstetric input is urgent for new HF during pregnancy or postpartum.
Nephrology, endocrinology, geriatrics, palliative care, rehabilitation, pharmacy, dietetics and mental-health services may be central rather than optional when their condition limits safe care. Referral is not abandonment: primary care can monitor symptoms, blood pressure, renal function, adherence barriers and vaccination while specialty care guides complex therapy. Indian service availability differs by region; identify the nearest facility with echocardiography, monitored acute care and appropriate specialist support before deterioration makes transport unsafe.
Red Flags
Red flags of acute decompensation are severe breathlessness at rest, inability to speak full sentences, cyanosis, low oxygen saturation, respiratory fatigue, pink frothy sputum, new confusion, cool clammy skin, hypotension, oliguria, syncope, chest pain, rapidly rising jugular venous pressure, or rapidly progressive oedema and weight gain. These indicate possible pulmonary oedema, shock, acute coronary syndrome, serious arrhythmia or another emergency, not merely ‘bad chronic HF’. Emergency assessment is urgent even if a person has a prior HF label.
New or worsening chest pain, dynamic ECG change, marked troponin elevation in an appropriate context, sudden palpitation with haemodynamic compromise, fever or sepsis signs, a new murmur, haemoptysis, unilateral pleuritic pain, recent immobilisation, pregnancy/postpartum symptoms or focal neurological deficit broadens the emergency differential. Fluid retention and renal decline can occur together, so falling urine output after an arbitrary diuretic increase is a warning to reassess perfusion, obstruction, medicines and infection rather than simply give more fluid or stop all treatment.
For stable patients, rapidly falling exercise capacity, escalating rescue diuretic use, recurrent nocturnal symptoms, persistent tachycardia, symptomatic hypotension, dizziness, syncope, medication intolerance, confusion about a new regimen or inability to obtain essential medicines needs early review. A normal LVEF does not neutralise these symptoms. Provide written return precautions in the patient’s preferred language and match them to local emergency access; this guide cannot specify a universal ambulance number or service threshold.
Indian Clinical Context
This guide is framed for Indian medical education and care discussions, but the core therapeutic sources are AHA/ACC/HFSA and ESC international guidelines. They are not an Indian prescribing law, national formulary or substitute for local protocols. Choice and sequence of medicines, monitoring, device access, referral thresholds and financing must be reconciled with the treating unit’s capabilities, current Indian labels and the individual’s preferences. No unsupported claim is made here about national availability or affordability of any HF drug, device or test.
A practical Indian assessment should actively ask about access to blood-pressure monitoring, laboratory follow-up, medicine stock, travel time, dietary pattern, salt-containing packaged foods or remedies, generic and brand duplication, NSAID self-treatment and support for daily symptom monitoring. These questions identify barriers without attributing non-adherence to character. Where echocardiography, natriuretic peptides, infusion pumps or intensive care are unavailable, the safest step may be early transfer after initial stabilisation rather than an improvised high-risk escalation.
Coronary disease, hypertension, diabetes, rheumatic or degenerative valve disease, anaemia, kidney disease, cardiomyopathy and pregnancy-related disease should be investigated according to phenotype and local epidemiology. Avoid treating fever, anaemia or a positive test as the complete explanation for congestion without cardiac assessment. The NMC curriculum provides the jurisdictional undergraduate framework; local hospitals must maintain their own acute-HF protocol, referral directory and medicine-monitoring system. Evidence gaps for Indian delivery and access should be stated in audit and teaching material, not hidden by international citations.
NMC Competency Mapping
The NMC Competency Based Medical Education Curriculum 2024 is the authoritative Indian framework for undergraduate learning, while the exact institutional competency numbers and phase schedule must be verified in the adopted curriculum ledger. HF integrates cardiovascular physiology, pathology, pharmacology, general medicine, emergency care, radiology, community medicine and communication. A learner should connect impaired cardiac filling or ejection to pulmonary or systemic congestion, then explain why EF is useful but does not by itself establish the syndrome.
At knowledge and reasoning levels, the learner should take a cardiovascular and medicine history; recognise orthopnoea, raised JVP, oedema, crackles, perfusion changes and murmurs; interpret ECG, chest radiograph, renal function, electrolytes, natriuretic peptides and echocardiography in context; and identify ischaemia, arrhythmia, infection, valvular disease, anaemia, renal dysfunction and medicine-related deterioration. They should distinguish chronic congestion from shock and provide a structured escalation.
Under supervision, students can counsel on medicine adherence, salt and fluid advice as locally prescribed, warning symptoms, follow-up and safe use of a written plan. They must not independently prescribe intravenous diuretics, vasodilators, inotropes, foundational HF medicines or potassium correction, decide device eligibility, interpret complex echo alone, or determine fitness for pregnancy. An OSCE can assess a congested but perfused patient and a shocked patient separately, rewarding ABC assessment, trigger search and appropriate referral. This mapping supports teaching and does not certify unsupervised competence or publication approval.
Key Exam Pearls for NEET PG
HF is a clinical syndrome, not an ejection-fraction number. HFrEF is LVEF 40% or less; mildly reduced EF is 41–49%; preserved EF is 50% or more with evidence of raised filling pressures. Recognise that a patient may have HF with preserved EF, and that a patient with a historical reduced EF may have acute dyspnoea from another cause. Orthopnoea, paroxysmal nocturnal dyspnoea, raised JVP, crackles, S3 and oedema are helpful but none is individually diagnostic.
In acute pulmonary oedema, assess oxygenation, work of breathing, perfusion, blood pressure, ECG and precipitant immediately. Cold, hypotensive, confused or oliguric patients may be in cardiogenic shock and need urgent monitored care. Search for acute coronary syndrome, arrhythmia, hypertensive emergency, infection, valve catastrophe and medication issues. Diuretics treat congestion; they are not a substitute for evaluating haemodynamics or cause.
For chronic HFrEF, remember the four foundational classes named by AHA/ACC/HFSA: renin-angiotensin system/ARNI pathway therapy as appropriate, evidence-based beta blocker, mineralocorticoid receptor antagonist and SGLT2 inhibitor. Exam recall must not erase contraindications: monitor renal function and potassium, avoid ACE inhibitor plus ARNI coadministration, and individualise therapy for blood pressure, volume status, pregnancy and comorbidity. NSAIDs can worsen fluid retention. Refer new HF, recurrent admission, valve disease, syncope, advanced symptoms and pregnancy-related HF for specialist assessment.
Frequently Asked Questions
Does ankle swelling alone prove that a person has heart failure?
No. Venous insufficiency, kidney disease, liver disease, medicines, lymphatic disease and other causes can produce oedema. Heart failure is diagnosed from symptoms and signs together with objective evidence of structural or functional cardiac abnormality and, where appropriate, raised natriuretic peptides or congestion. The cause of new swelling still needs assessment.
Can a person have heart failure when the ejection fraction is normal?
Yes. HF with preserved ejection fraction requires symptoms and signs plus evidence of raised filling pressures; a normal or preserved LVEF does not rule out the syndrome. Conversely, an EF result alone does not establish the cause of current breathlessness. Echocardiography, peptides, examination, comorbidities and trajectory need integrated interpretation.
Why are kidney function and potassium checked after changing heart failure medicines?
Diuretics and disease-modifying treatments can alter intravascular volume, renal perfusion and potassium balance. The aim is not to deny effective therapy after any laboratory change, but to detect dangerous hyperkalaemia, hypokalaemia, dehydration, hypotension or renal deterioration early and adjust treatment using symptoms, examination, trend and a local monitoring protocol.
What should prompt urgent assessment rather than waiting for follow-up?
Severe breathlessness at rest, low oxygen saturation, chest pain, fainting, confusion, cold clammy skin, low blood pressure, very low urine output, rapid palpitations with instability, pink frothy sputum or a sudden major decline in exercise tolerance require urgent assessment. These may reflect pulmonary oedema, shock, acute coronary syndrome, arrhythmia or another emergency.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic